Analytical Data
-
Gene name
PGA4
- Application
-
Alternative Names
PGA4；Pepsin A-4
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0DJD7
-
Expression Region
63-388aa
-
AA Sequence
VDEQPLEN YLDMEYFGTI GIGTPAQDFT VVFDTGSSNL WVPSVYCSSL ACTNHNRFNP EDSSTYQSTS ETVSITYGTG SMTGILGYDT VQVGGISDTN QIFGLSETEP GSFLYYAPFD GILGLAYPSI SSSGATPVFD NIWNQGLVSQ DLFSVYLSAD DQSGSVVIFG GIDSSYYTGS LNWVPVTVEG YWQITVDSIT MNGEAIACAE GCQAIVDTGT SLLTGPTSPI ANIQSDIGAS ENSDGDMVVS CSAISSLPDI VFTINGVQYP VPPSAYILQS EGSCISGFQG MNLPTESGEL WILGDVFIRQ YFTVFDRANN QVGLAPVA
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PGA4 is a member of the pathogenesis-related protein 4 (PR-4) family, which plays a crucial role in plant defense mechanisms against pathogens. Originally identified in plants, PGA4 has garnered interest due to its potential applications in agriculture, specifically in enhancing disease resistance in crops. Research has shown that PGA4 can be involved in the synthesis of antimicrobial compounds and may facilitate the plant's response to biotic and abiotic stresses. Understanding the structure and functional mechanisms of PGA4 is essential for developing biotechnological strategies aimed at improving crop resilience and productivity. Recent advances in molecular biology techniques, including gene editing and recombinant protein production, have opened new avenues for studying PGA4, enabling scientists to elucidate its role in plant immune responses further. Investigating PGA4’s potential for use in transgenic crops could lead to more sustainable agricultural practices by reducing the reliance on chemical pesticides, thus contributing to food security and environmental conservation. Additionally, the insights gained from PGA4 research may extend beyond agriculture, offering potential applications in biotechnology and medicine, by harnessing the protein's properties for therapeutic uses. Overall, the exploration of PGA4 has significant implications for enhancing plant health and resilience in an era of increasing agricultural challenges.
